<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01052350</url>
  </required_header>
  <id_info>
    <org_study_id>06-0706-201103106</org_study_id>
    <nct_id>NCT01052350</nct_id>
  </id_info>
  <brief_title>PET Imaging in Parkinson Disease Dementia</brief_title>
  <official_title>Investigations of Dementia in Parkinson Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Washington University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Washington University School of Medicine</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to use a brain imaging method called PIB PET to determine&#xD;
      dementia subtypes in patients with Parkinson's disease. The ultimate goal of this project is&#xD;
      to be able to identify individuals with PD who are at risk of developing dementia, and to&#xD;
      distinguish the underlying cause of dementia.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this study is to use a brain imaging method called PIB PET to determine&#xD;
      dementia subtypes in patients with Parkinson's disease. The ultimate goal of this project is&#xD;
      to be able to identify individuals with PD who are at risk of developing dementia, and to&#xD;
      distinguish the underlying cause of dementia. We will be including both PD and normal&#xD;
      subjects in this study. This a long term study and we are considering including a total of&#xD;
      320 participants in this protocol.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>August 2006</start_date>
  <completion_date type="Anticipated">July 2030</completion_date>
  <primary_completion_date type="Anticipated">July 2030</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">320</enrollment>
  <condition>Parkinson's Disease</condition>
  <arm_group>
    <arm_group_label>Parkinson disease</arm_group_label>
    <description>individuals with Parkinson disease</description>
  </arm_group>
  <arm_group>
    <arm_group_label>healthy control</arm_group_label>
    <description>individuals without Parkinson disease</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      whole blood&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Participants with and without Parkinson disease will be recruited from the Movement&#xD;
        Disorders Center at Washington University, the St. Louis metro area, and throughout the&#xD;
        midwest region.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  PD patients must exhibit three of the following cardinal signs: rest tremor, rigidity,&#xD;
             bradykinesia, or postural instability; or two of these features with one of the first&#xD;
             three displaying asymmetry.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  history of head trauma, major neurological or psychiatric diseases other than&#xD;
             Parkinson disease and dementia, e.g. stroke, multiple sclerosis, depression or&#xD;
             schizophrenia&#xD;
&#xD;
          -  severe systemic diseases&#xD;
&#xD;
          -  inability to lie still for 90 minutes&#xD;
&#xD;
          -  metallic implants, pacemakers, or any other contraindication to MRI&#xD;
&#xD;
          -  refusal to consent to brain donation&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joel S. Perlmutter, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Washington University School of Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>NeuroClinical Research Unit (NCRU), Washington University School of Medicine</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>January 15, 2010</study_first_submitted>
  <study_first_submitted_qc>January 15, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 20, 2010</study_first_posted>
  <last_update_submitted>May 12, 2021</last_update_submitted>
  <last_update_submitted_qc>May 12, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 13, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Parkinson disease</keyword>
  <keyword>PET imaging</keyword>
  <keyword>PIB</keyword>
  <keyword>dementia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Parkinson Disease</mesh_term>
    <mesh_term>Dementia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

